Evidence for a deleterious role of visfatin was presented in a recent study in which a visfatin-neutralizing antibody reduced remodelling and improved cardiac function in rats subjected to a sustained 4-week myocardial infarction via inhibition of the visfatin/TLR4 inflammatory cascade [125]. Here, TLR4 is linked to myocardial infarction.